The dual inhibition of COX-2 and 5-LOX thus represents a promising strategy to address the interplay between inflammation and the cholinergic system, potentially alleviating cognitive symptoms and slowing the progression of neurodegeneration in AD. This evidence concerns the gene PTGS2 and Alzheimer disease.